Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Amortization of Deferred Charges (2019 - 2021)

Utah Medical Products' quarterly Amortization of Deferred Charges came in at $11000.0 in Q3 2021, up 10.0% year-on-year from $10000.0 in Q3 2020, and little changed quarter-over-quarter from $11000.0 in Q2 2021.

Utah Medical Products has reported Amortization of Deferred Charges for 3 years, with the latest figure at $11000.0 in Q3 2021.

  • For the quarter ending Q3 2021, Amortization of Deferred Charges rose 10.0% year-over-year to $11000.0; the trailing twelve-month figure through Sep 2021 stood at $42000.0 (up 10.53% YoY), and the FY2020 full-year result was $39000.0, up 2.63% from the prior year.
  • Amortization of Deferred Charges for Q3 2021 stood at $11000.0, roughly flat from $11000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $11000.0 in Q2 2021, with the low at $9000.0 in Q2 2019.
  • Average Amortization of Deferred Charges over 3 years is $9909.1, with a median of $10000.0 recorded in 2019.
  • Peak annual rise in Amortization of Deferred Charges reached 11.11% in 2020, while the deepest fall reached 10.0% in 2020.
  • Tracing UTMD's Amortization of Deferred Charges over 3 years: stood at $9000.0 in 2019, then advanced by 11.11% to $10000.0 in 2020, then increased by 10.0% to $11000.0 in 2021.
  • The last three Amortization of Deferred Charges figures came in at $11000.0 (Q3 2021), $11000.0 (Q2 2021), and $10000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 11,000.00
Sep 30, 2021 11,000.00
Jun 30, 2021 11,000.00
Jun 30, 2021 11,000.00
Mar 31, 2021 10,000.00
Mar 31, 2021 10,000.00
Dec 31, 2020 10,000.00
Dec 31, 2020 10,000.00
Sep 30, 2020 10,000.00
Sep 30, 2020 10,000.00
Jun 30, 2020 10,000.00
Jun 30, 2020 10,000.00
Mar 31, 2020 9,000.00
Mar 31, 2020 9,000.00
Dec 31, 2019 9,000.00
Dec 31, 2019 9,000.00
Sep 30, 2019 10,000.00
Sep 30, 2019 10,000.00
Jun 30, 2019 9,000.00
Jun 30, 2019 9,000.00
Mar 31, 2019 10,000.00
Mar 31, 2019 10,000.00